Sorafenib-Induced Acute Pancreatitis: Case Report and Review of the Literature

Excerpt

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the third leading cause of cancer-related death worldwide [1]. The reported annual incidence of HCC is rising in most countries, mostly due to the increasing burden of chronic hepatitis B and hepatitis C virus (HCV), along with the prevalence of other risk factors such as excessive alcohol consumption. Although new HCV therapies have proven effective, they are often expensive and not always universally accessible. Additionally, the increased incidence of non-alcoholic fatty liver disease secondary to obesity and diabetes contribute to new cases of HCC, especially in developed countries such as the USA [2‐4]. …